Navellier & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,998
Closed -$1.89M 334
2022
Q1
$1.89M Sell
9,998
-192
-2% -$38K 0.32% 94
2021
Q4
$2.49M Sell
10,190
-80
-0.8% -$17.5K 0.36% 82
2021
Q3
$1.99M Buy
10,270
+31
+0.3% +$6.26K 0.3% 98
2021
Q2
$1.91M Sell
10,239
-187
-2% -$32.5K 0.29% 97
2021
Q1
$1.64M Sell
10,426
-49,060
-82% -$7.77M 0.3% 97
2020
Q4
$9.85M Sell
59,486
-15,528
-21% -$2.53M 1.78% 8
2020
Q3
$12.4M Sell
75,014
-2,408
-3% -$370K 2.71% 3
2020
Q2
$10.6M Sell
77,422
-9,246
-11% -$1.21M 2.52% 5
2020
Q1
$10.2M Sell
86,668
-9,999
-10% -$1.32M 2.4% 5
2019
Q4
$12.8M Sell
96,667
-1,683
-2% -$209K 2.06% 5
2019
Q3
$12.3M Sell
98,350
-286
-0.3% -$34.5K 2.03% 7
2019
Q2
$11.2M Sell
98,636
-957
-1% -$100K 1.73% 13
2019
Q1
$10M Sell
99,593
-46
-0% -$4.18K 1.56% 10
2018
Q4
$8.52M Buy
99,639
+46,503
+88% +$4.19M 1.45% 6
2018
Q3
$4.87M Buy
53,136
+2,406
+5% +$213K 0.63% 42
2018
Q2
$4.32M Buy
50,730
+28,327
+126% +$2.39M 0.6% 41
2018
Q1
$1.87M Buy
22,403
+13,995
+166% +$1.1M 0.28% 106
2017
Q4
$606K Buy
+8,408
New +$577K 0.11% 163

Other funds holding ZTS

Navellier & Associates's ZTS Position: Q2 2022 in Review

Navellier & Associates sold out of Zoetis (ZTS) in Q2 2022, closing a stake of 9,998 shares — an estimated $1.89M sold.

Navellier & Associates first reported a position in ZTS in Q4 2017 and held it in 18 quarters. The position peaked at $12.8M in Q4 2019. 1,563 funds tracked by Wall St. Rank hold ZTS as of Q2 2022.

  • Navellier & Associates reported no remaining Zoetis position as of Q2 2022 after selling out during the quarter.
  • Navellier & Associates sold 9,998 Zoetis shares in Q2 2022, an estimated $1.89M.
  • Navellier & Associates first reported a position in Zoetis in Q4 2017 and held it in 18 quarters.
  • Navellier & Associates's Zoetis position peaked at $12.8M in Q4 2019.
  • 1,563 funds tracked by Wall St. Rank held Zoetis as of Q2 2022.

Based on Navellier & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.